National Childrens Leukemia Brooklyn, NY - 11234

National Childrens Leukemia is categorized under Promotions and Fund Raising in Brooklyn, NY and active since 1991.

National Childrens Leukemia was established in 1991, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Promotions and Fund Raising business, which does work in the B2B market, and is classified as a Promotions and Fund Raising, under code number 5222910 by the NAICS.

If you are seeking more information, feel free to contact Steve Shor, President at the company’s single location by writing to 7316 Avenue U, Brooklyn, New York NY 11234 or by phoning (718) 251-1133. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: National Childrens Leukemia
Contact Person: Steve Shor, President
Address: 7316 Avenue U, Brooklyn, New York 11234
Phone Number: (718) 251-1133
Annual Revenue (USD): $1.000.000 to $2.499.999
Founded: 1991
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Promotions and Fund Raising
SIC Code: 7389
NAICS Code: 5222910
Share This Business:

National Childrens Leukemia was started in 1991 to provide professional Promotions and Fund Raising under the SIC code 7389 and NAICS code 5222910. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.

Feel free to contact Steve Shor, President for inquiries that concern National Childrens Leukemia by calling the company number (718) 251-1133, as your correspondence is most welcome. Additionally, the physical location of the single location of National Childrens Leukemia can be found at the coordinates 40.620945,-73.905617 as well as the street address 7316 Avenue U in Brooklyn, New York 11234.

For its online presence, you may visit National Childrens Leukemia’s website at and engage with its social media outlets through on Twitter and on Facebook.